science top stories popular news  

Daily non-political popular news in brief.

New vaccine may provide broader protection against cervical cancer

06-28-2007 · EurekAlert!

Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.

Read more »

Keywords: vaccine, provide, broader, protection, cervical, cancer

« Previous | Next »

Similar news on "New vaccine may provide broader protection against cervical cancer":

  1. Pancreatic cancer vaccine halts progression of disease in some patients
    04-17-2007 · EurekAlert!
    A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
    Similar news · Read more »
  2. Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
    05-09-2007 · EurekAlert!
    A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancer. Researchers at more than a dozen international medical centers evaluated the efficacy of quadrivalent vaccine targeting HPV types 6, 11, 16 and 18 in more than 12,000 women ages 15 to 26 in 13 countries for nearly three years. They found a near 100 percent efficacy rate in prevention of HPV types 16 and 18.
    Similar news · Read more »
  3. International studies show high efficacy for HPV vaccine
    05-31-2007 · EurekAlert!
    A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancerСstrains 16 and 18. Researchers combined and analyzed the data from four randomized trials that involved 20,583 women ages 15 to 26 from more than two dozen countries. Researchers found that the prophylactic administration of the vaccine was highly effective in preventing pre-malignant changes of the cervix.
    Similar news · Read more »
  4. Residual fetal cells in women may provide protection against breast cancer
    10-01-2007 · EurekAlert!
    Fetal cells that persist in a woman's body long after pregnancy -- a common occurrence known in scientific circles as fetal microchimerism -- in some cases may reduce the woman's risk of breast cancer, according to researchers at Fred Hutchinson Cancer Research Center.
    Similar news · Read more »
  5. Universal flu vaccine being tested on humans
    07-17-2007 · EurekAlert!
    A universal influenza vaccine that has been pioneered by researchers from VIB and Ghent University is being tested for the first time on humans by the British-American biotech company Acambis. This vaccine is intended to provide protection against all "A" strains of the virus that causes human influenza, including pandemic strains.
    Similar news · Read more »
  6. Diet can provide protection against development of certain cancers, new studies show
    11-14-2006 · EurekAlert!
    With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate. But studies into the association between diet and cancer show that food can have an impact in preventing cancer, or in reducing the aggressiveness of the disease.
    Similar news · Read more »
  7. New picture of HIV-1's protein jacket identifies target for antibody-based vaccine
    01-10-2008 · EurekAlert!
    By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, or so-called broadly neutralizing, antibodies block HIV-1 infection. The discovery may provide scientists with an attractive target for antibody-based vaccine.
    Similar news · Read more »
  8. Painkillers may threaten power of vaccines
    11-28-2006 · EurekAlert!
    With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea.
    Similar news · Read more »
  9. Temple University Hospital investigates new prophylactic HPV vaccine
    01-30-2007 · EurekAlert!
    Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
    Similar news · Read more »
  10. Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released
    10-10-2007 · EurekAlert!
    A first-in-man trial of a live Listeria vaccine was reported by Advaxis Inc. at the World Vaccine Conference in Lyon, France.
    Similar news · Read more »